Sepiapterin FDA approval date

The FDA approved Sepiapterin (PTC923) on 28 Jul 2025.

FDA approval date
28 Jul 2025

Drug identity checked against registry records

Also recorded as PTC923; Sephience

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)NCT06302348PTC TherapeuticsPhase 3Recruiting2031-02-28Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-07-28DaySepiapterinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219666", "applicant_as_listed_by_fda": "PTC THERAP", "brand_names": ["SEPHIENCE"], "active_ingredients": ["SEPIAPTERIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250728", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026